How To Use CPT Code 0694T

CPT 0694T describes the use of 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue during a surgical procedure, such as mastectomy. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0694T?

CPT 0694T can be used to describe the use of a specialized system to obtain 3-dimensional imaging and reconstruction of a breast or axillary lymph node tissue specimen during a surgical procedure, such as mastectomy. This code is used when the provider utilizes this technology to better visualize and interpret the excised tissue specimen, including automatic specimen reorientation, for improved accuracy and detection of cancerous tissue.

2. Official Description

The official description of CPT code 0694T is: ‘3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue, each excised specimen, 3-dimensional automatic specimen reorientation, interpretation and report, real-time intraoperative.’

3. Procedure

1. During a surgical procedure, such as mastectomy, the provider uses a specialized system to obtain 3-dimensional imaging and reconstruction of a breast or axillary lymph node tissue specimen.
2. The imaging and reconstruction are three-dimensional (3D), providing a more comprehensive view of the excised tissue specimen.
3. The system also includes automatic specimen reorientation, which enhances visualization and interpretation of the tissue.
4. The provider performs the imaging and reconstruction in real-time intraoperatively, allowing for immediate interpretation and reporting of the findings.

4. Qualifying circumstances

CPT 0694T is used when a provider performs 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue during a surgical procedure, such as mastectomy. This code is applicable when the imaging and reconstruction are performed on each excised specimen, and when the provider utilizes the automatic specimen reorientation feature of the specialized system. The service includes interpretation and reporting of the findings.

5. When to use CPT code 0694T

CPT code 0694T should be used when a provider performs 3-dimensional volumetric imaging and reconstruction of breast or axillary lymph node tissue during a surgical procedure, such as mastectomy. This code is not appropriate for other types of procedures or imaging techniques. It is important to ensure that the service meets the specific criteria outlined in the official description.

6. Documentation requirements

To support a claim for CPT code 0694T, the provider must document the following information:

• Description of the surgical procedure performed
• Specific details of the 3-dimensional volumetric imaging and reconstruction process
• Date and time of the service
• Interpretation and report of the findings
• Signature of the provider performing the service

7. Billing guidelines

When billing for CPT code 0694T, ensure that the service meets the criteria outlined in the official description. It is important to note that CPT code 0694T should not be reported in conjunction with code 76098. Additionally, this code should be reported once per specimen. It is essential to follow the specific billing guidelines provided by the payer to ensure accurate reimbursement.

8. Historical information

CPT code 0694T was added to the Current Procedural Terminology system on January 1, 2022. As a Category III code, it is a temporary code used to collect information about the use and efficacy of investigational technologies and procedures. The inclusion of this code does not imply agreement concerning efficacy, safety, or appropriateness of the procedure to clinical practice or payer reimbursement.

9. Examples

1. A surgeon performing a mastectomy utilizes 3-dimensional volumetric imaging and reconstruction to better visualize and interpret the excised breast tissue specimen, including automatic specimen reorientation, for accurate detection of cancerous tissue.
2. During a surgical procedure, a provider uses a specialized system to obtain 3-dimensional imaging and reconstruction of axillary lymph node tissue, enhancing the accuracy of interpretation and reporting.
3. Using the advanced technology available, a surgeon performs 3-dimensional volumetric imaging and reconstruction of breast tissue during a mastectomy, providing a comprehensive view of the excised specimen and aiding in the identification of cancerous tissue.
4. During a mastectomy procedure, a provider utilizes 3-dimensional imaging and reconstruction to better visualize and interpret the excised axillary lymph node tissue, improving the detection of cancerous cells.
5. A surgeon performs a mastectomy and employs 3-dimensional volumetric imaging and reconstruction of breast tissue, including automatic specimen reorientation, to enhance the accuracy of interpretation and reporting.
6. Utilizing the specialized system, a provider obtains 3-dimensional imaging and reconstruction of axillary lymph node tissue during a surgical procedure, aiding in the identification of cancerous cells and providing valuable information for treatment planning.
7. During a mastectomy, a surgeon uses 3-dimensional volumetric imaging and reconstruction to obtain a comprehensive view of the excised breast tissue specimen, facilitating accurate interpretation and reporting of the findings.
8. A provider performs 3-dimensional imaging and reconstruction of axillary lymph node tissue during a surgical procedure, assisting in the detection and characterization of cancerous cells.
9. Using the advanced technology available, a surgeon obtains 3-dimensional volumetric imaging and reconstruction of breast tissue during a mastectomy, improving the visualization and interpretation of the excised specimen.
10. During a surgical procedure, a provider utilizes 3-dimensional imaging and reconstruction to obtain a detailed view of axillary lymph node tissue, aiding in the identification of cancerous cells and informing treatment decisions.